Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cerigel
2. Tserigel
1. 123-03-5
2. Hexadecylpyridinium Chloride
3. 1-hexadecylpyridin-1-ium Chloride
4. 1-hexadecylpyridinium Chloride
5. Pristacin
6. Cetamium
7. Ceprim
8. Dobendan
9. Pyrisept
10. Tserigel
11. Aktivex
12. Biosept
13. Cepacol
14. 1-cetylpyridinium Chloride
15. Ceepryn Chloride
16. Cepacol Chloride
17. Quaternario Cpc
18. Acetoquat Cpc
19. Intexsan Cpc
20. Swabettes Hoechst
21. Ammonyx Cpc
22. N-hexadecylpyridinium Chloride
23. Cetyl Pyridinium Chloride
24. Pyridinium, 1-hexadecyl-, Chloride
25. N-cetylpyridinium Chloride
26. Cetylpyridinium Chloride Anhydrous
27. Hexadecyl Pyridinium Chloride
28. 1-palmitylpyridinium Chloride
29. Cetylpyridinii Chloridum
30. Cloruro De Cetilpiridinio
31. Chlorure De Cetylpyridinium
32. Cetylpyridinium Chloride [inn]
33. Cetylpyridinium (chloride)
34. 6br7t22e2s
35. Chebi:32915
36. Nsc-14864
37. Medilave
38. Merocet
39. 1-hexadecylpyridin-1-ium;chloride
40. Ceeprin Chloride
41. Cetylpyridini Chloridum
42. Caswell No. 166a
43. Hsdb 38
44. Cetilpiridinio Cloruro [dcit]
45. Cetilpiridinio Cloruro
46. Einecs 204-593-9
47. Cetylpyridinii Chloridum [inn-latin]
48. Nsc 14864
49. Epa Pesticide Chemical Code 069160
50. Unii-6br7t22e2s
51. Cloruro De Cetilpiridinio [inn-spanish]
52. Chlorure De Cetylpyridinium [inn-french]
53. Ai3-15070
54. Cetyl Pyridinium Chlorine
55. Nb 002
56. 1-hexadecylpyridinium Chloride (1:1)
57. Cetyl-pyridinium Chloride
58. Schembl4763
59. Dsstox_cid_21761
60. Dsstox_rid_79838
61. Dsstox_gsid_41761
62. Chembl34833
63. Spectrum1500169
64. 1-hexadecyl-pyridinium Chloride
65. Dtxsid6041761
66. 1-hexadecylpyridin-1-iumchloride
67. Hms501b08
68. Hms1920m13
69. Hms2091a20
70. Hms3652f05
71. Pharmakon1600-01500169
72. 1-hexadecylpyridine Chloride Hydrate
73. Act02661
74. Hy-b1464
75. Nsc14864
76. Tox21_301296
77. 1-cetylpyridinium Chloride 1-hydrate
78. Ccg-39719
79. Cetylpyridinium Chloride [mi]
80. Mfcd00011731
81. Nsc756673
82. S4172
83. Akos005267197
84. Cetylpyridinium Chloride [hsdb]
85. Ks-5309
86. Wln: T6kj A16 & Q & G
87. Cetylpyridinium Chloride [who-dd]
88. Ncgc00094618-01
89. Ncgc00094618-02
90. Ncgc00257543-01
91. Ac-32490
92. Cas-123-03-5
93. Db-041704
94. Pyridinium, 1-hexadecyl-, Chloride (1:1)
95. Cs-0013168
96. Ft-0602586
97. H0078
98. Sw222237-1
99. A16439
100. F20369
101. A832584
102. A890863
103. Q418318
104. Sr-05000001582
105. Sr-05000001582-1
106. W-105282
Molecular Weight | 340.0 g/mol |
---|---|
Molecular Formula | C21H38ClN |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 15 |
Exact Mass | 339.2692779 g/mol |
Monoisotopic Mass | 339.2692779 g/mol |
Topological Polar Surface Area | 3.9 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 208 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-infective Agents, Local
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
A LOCAL ANTI-INFECTIVE WHICH POSSESSES SURFACE-ACTIVE AS WELL AS ANTISEPTIC PROPERTIES AGAINST SENSITIVE NONSPORULATING BACTERIA ... USED FOR PREOPERATIVE PREPN OF SKIN FOR PROPHYLACTIC ANTISEPSIS OF MINOR WOUNDS & ... IRRIGATION OF OR TOPICAL APPLICATION TO MUCOUS MEMBRANES. ... ALSO INCORPORATED INTO MOUTHWASHES.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1090
A CATIONIC SURFACE-AGENT ... BACTERICIDAL OR BACTERIOSTATIC AGAINST MANY GRAM-POSITIVE & GRAM-NEG ORGANISMS. ... ALSO ACTIVE AGAINST SOME FUNGI, INCL CANDIDA ALBICANS, & AGAINST TRICHOMONAS VAGINALIS, BUT IS NOT AN EFFECTIVE ANTI-INFECTIVE ... FOR SPORES OR MOST VIRUSES.
American Hospital Formulary Service. Volumes I and II. Washington, DC: American Society of Hospital Pharmacists, to 1984., p. 84:4:16
DOSAGE: TOPICAL, AS A 1:100 TO 1:1000 SOLN TO INTACT SKIN; 1:1000 FOR MINOR LACERATIONS; 1:2000 TO 1:10,000 TO MUCOUS MEMBRANES; 0.33 TO 3 MG IN LOZENGES OR TROCHES; FOR INSERTION INTO RECTUM, 0.05%. DOSAGE FORMS- LOZENGES NF: 1.5 MG IN 1:1500 CONCN; SOLN NF: 1:1000.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1090
For more Therapeutic Uses (Complete) data for CETYLPYRIDINIUM CHLORIDE (16 total), please visit the HSDB record page.
QUATERNARY AMMONIUM ANTISEPTICS ... APPLIED TO SKIN ... FORM FILM UNDER WHICH BACTERIA MAY REMAIN VIABLE EVEN THOUGH OUTER SURFACE OF FILM IS BACTERICIDAL. SINCE CETYLPYRIDINIUM CHLORIDE IS INACTIVATED BY SOAPS, SOAP USED IN PRE-OPERATIVE TREATMENT OF SKIN MUST BE THOROUGHLY REMOVED ... BEFORE APPLICATION OF ANTISEPTIC.
American Hospital Formulary Service. Volumes I and II. Washington, DC: American Society of Hospital Pharmacists, to 1984., p. 84:4:16
GRAM NEGATIVE ORGANISMS, INCL STRAINS OF PSEUDOMONAS AERUGINOSA, ARE MORE RESISTANT /THAN GRAM POS/ & REQUIRE LONGER EXPOSURE /TO QUATERNARY AMMONIUM CMPD/. /QUATERNARY AMMONIUM CMPD/
American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 890
ABSORBED AND INACTIVATED BY COTTON FABRICS, CELLULOSE SPONGES, CERTAIN PLASTICS (PARTICULARLY POLYVINYL CHLORIDE) OR OTHER POROUS MATERIALS. FOR THIS REASON, THESE AGENTS SHOULD NOT BE USED FOR COLD STERILIZATION OF CATHETERS, FLEXIBLE ENDOSCOPES OR OTHER INSTRUMENTS. /QUATERNARY AMMONIUM CMPD/
American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1439
CAN CAUSE OCCASIONAL ALLERGIC RESPONSES WITH CHRONIC USE, AS WITH CERTAIN DEODORANT PREPN & DIAPER WASHES. /CATIONIC SURFACTANTS/
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1002
/DUE TO ADSORPTION TENDENCY/ ... REPEATED USE OF SAME SOLN FOR DISINFECTION OF POROUS MATERIALS CAN REDUCE THE CONCN OF THE AGENT BELOW THE BACTERICIDAL LIMIT. /CATIONIC SURFACTANTS/
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1002
ORAL RETENTION OF CETYLPYRIDINIUM CHLORIDE GIVEN AS 1 MIN MOUTH RINSE OF 10 ML OF 2.2 MMOL SOLN WAS 65% OF ADMIN DOSE.
BONESVOLL P, GJERMO P; ARCH ORAL BIOL 23 (4) 289-94 (1978)
MODE OF ACTION ... NOT YET FULLY UNDERSTOOD BUT HAS BEEN ASCRIBED TO ... THE DENATURING OF LIPOPROTEIN COMPLEXES, & POSSIBLY OTHER ACTIONS. /QUATERNARY AMMONIUM COMPD/
American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 890
EVIDENCE HAS BEEN PRESENTED THAT THE MAJOR SITE OF ACTION ... MAY BE THE CELL MEMBRANE, WHERE THE AGENTS MAY CAUSE CHANGES IN PERMEABILITY THAT PERMIT ESCAPE OF ENZYMES, COENZYMES, & METABOLIC INTERMEDIATES. /CATIONIC SURFACTANTS/
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1001
EMULSIFY SEBACEOUS MATERIAL, WHICH IS THEN REMOVED TOGETHER WITH DIRT & BACTERIA. THE MILD DESQUAMATING EFFECT OF THE QUATERNARY AMMONIUM COMPOUNDS AIDS IN CLEANING. /QUATERNARY AMMONIUM COMPD/
American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1439
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20349
Submission : 2007-03-16
Status : Active
Type : II
Date of Issue : 2022-09-16
Valid Till : 2025-07-22
Written Confirmation Number : WC-0136n
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8029
Submission : 1989-04-19
Status : Active
Type : II
Date of Issue : 2015-06-15
Valid Till : 2018-06-15
Written Confirmation Number : WC-0333
Address of the Firm :
Certificate Number : CEP 2001-265 - Rev 04
Issue Date : 2024-01-23
Type : Chemical
Substance Number : 379
Status : Valid
NDC Package Code : 25441-6060
Start Marketing Date : 2015-05-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2020-08-07
Valid Till : 2023-08-06
Written Confirmation Number : WC-0483
Address of the Firm :
NDC Package Code : 25119-0256
Start Marketing Date : 2013-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : CEP 2007-029 - Rev 07
Issue Date : 2024-07-15
Type : Chemical
Substance Number : 379
Status : Valid
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata...
About the Company : Biesterfeld Spezialchemie GmbH is a part of the Biesterfeld Group. Biesterfeld Spezialchemie GmbH is a pan-European, rapidly growing distributor of products requiring special perfo...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : RELIANCE RASAYAN PVT. LTD (RRPL) was established in 1988 and in 2016 entered in pharma solutions business. Thus started our journey of developing advanced pharmaceutical intermedia...
About the Company : Unilab Chemicals & Pharmaceuticals Pvt. Ltd. is a quality manufacturer of API's, Bulk Drugs & Formulations. The Company specializes in the manufacture of antiseptics and disinfect...
About the Company : Vertellus develops & manufactures intermediates, APIs, & excipients for the pharmaceutical sector, in an FDA approved cGMP facility. Other products include pyridine-based raw mater...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The trial, named the ARMS-I COVID Study, is designed to assess whether ARMS-I helps prevent airborne transmission of coronavirus and whether it reduces the symptoms of healthcare providers who have tested positive for the virus.
Lead Product(s): Cetylpyridinium Chloride
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 06, 2020
Lead Product(s) : Cetylpyridinium Chloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
UH to Launch Clinical Trial in the Fight to Protect Clinicians Against COVID-19
Details : The trial, named the ARMS-I COVID Study, is designed to assess whether ARMS-I helps prevent airborne transmission of coronavirus and whether it reduces the symptoms of healthcare providers who have tested positive for the virus.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 06, 2020
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
12 Aug 2021
Reply
30 Jul 2021
Reply
13 Apr 2021
Reply
25 Mar 2021
Reply
11 Jan 2021
Reply
01 Dec 2020
Reply
12 Oct 2020
Reply
10 Oct 2019
Reply
12 Oct 2018
REF. STANDARDS & IMPURITIES
Cetylpyridinium Chloride (500 mg)
CAS Number : 6004-24-6
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1104006
Current Lot : J2K032
Previous Lot : J1K032 (31-AUG-2017)
NDC Code :
Cetylpyridinium Chloride (500 mg)
CAS Number : 6004-24-6
Quantity Per Vial : 500
Sale Unit : mg
Price : $245.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1104006 / J2K032
ABOUT THIS PAGE
A Cetylpyridinium Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetylpyridinium Chloride, including repackagers and relabelers. The FDA regulates Cetylpyridinium Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetylpyridinium Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cetylpyridinium Chloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cetylpyridinium Chloride supplier is an individual or a company that provides Cetylpyridinium Chloride active pharmaceutical ingredient (API) or Cetylpyridinium Chloride finished formulations upon request. The Cetylpyridinium Chloride suppliers may include Cetylpyridinium Chloride API manufacturers, exporters, distributors and traders.
click here to find a list of Cetylpyridinium Chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cetylpyridinium Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Cetylpyridinium Chloride active pharmaceutical ingredient (API) in detail. Different forms of Cetylpyridinium Chloride DMFs exist exist since differing nations have different regulations, such as Cetylpyridinium Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cetylpyridinium Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. Cetylpyridinium Chloride USDMF includes data on Cetylpyridinium Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cetylpyridinium Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cetylpyridinium Chloride suppliers with USDMF on PharmaCompass.
A Cetylpyridinium Chloride CEP of the European Pharmacopoeia monograph is often referred to as a Cetylpyridinium Chloride Certificate of Suitability (COS). The purpose of a Cetylpyridinium Chloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cetylpyridinium Chloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cetylpyridinium Chloride to their clients by showing that a Cetylpyridinium Chloride CEP has been issued for it. The manufacturer submits a Cetylpyridinium Chloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cetylpyridinium Chloride CEP holder for the record. Additionally, the data presented in the Cetylpyridinium Chloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cetylpyridinium Chloride DMF.
A Cetylpyridinium Chloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cetylpyridinium Chloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cetylpyridinium Chloride suppliers with CEP (COS) on PharmaCompass.
A Cetylpyridinium Chloride written confirmation (Cetylpyridinium Chloride WC) is an official document issued by a regulatory agency to a Cetylpyridinium Chloride manufacturer, verifying that the manufacturing facility of a Cetylpyridinium Chloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cetylpyridinium Chloride APIs or Cetylpyridinium Chloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Cetylpyridinium Chloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Cetylpyridinium Chloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cetylpyridinium Chloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cetylpyridinium Chloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cetylpyridinium Chloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cetylpyridinium Chloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cetylpyridinium Chloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cetylpyridinium Chloride suppliers with NDC on PharmaCompass.
Cetylpyridinium Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cetylpyridinium Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cetylpyridinium Chloride GMP manufacturer or Cetylpyridinium Chloride GMP API supplier for your needs.
A Cetylpyridinium Chloride CoA (Certificate of Analysis) is a formal document that attests to Cetylpyridinium Chloride's compliance with Cetylpyridinium Chloride specifications and serves as a tool for batch-level quality control.
Cetylpyridinium Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Cetylpyridinium Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cetylpyridinium Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Cetylpyridinium Chloride EP), Cetylpyridinium Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cetylpyridinium Chloride USP).
LOOKING FOR A SUPPLIER?